Author(s):
Abdellatif Bouayyadi, Ahmed Moussaif, Lahcen Bouayyadi, Aboubaker El Hessni, El Mokhtar Essassi, Mohammed El Mzibri, Abdelhalem Mesfioui
Email(s):
abdellatif_bouayyadi@yahoo.fr
DOI:
10.52711/0974-360X.2022.00404 
Address:
Abdellatif Bouayyadi1,2*, Ahmed Moussaif1, Lahcen Bouayyadi4, Aboubaker El Hessni2, El Mokhtar Essassi3, Mohammed El Mzibri1, Abdelhalem Mesfioui2
1Division of Life Sciences – National Center for Energy Sciences and Nuclear Techniques – Rabat – Morocco.
2Biology and Health Laboratory – Faculty of Sciences, Ibn Tofail University – Kenitra – Morocco.
3Heterocyclic Organic Chemistry Laboratory Pharmacochemistry Competence Center - Mohammed V - Agdal University Faculty of Sciences - Rabat Morocco.
4Biodiversity and Natural Resources Laboratory - Faculty of Sciences, Ibn Tofaïl University Kenitra – Morocco.
*Corresponding Author
Published In:
Volume - 15,
Issue - 6,
Year - 2022
ABSTRACT:
3-[2-(1H-Benzimidazol-2-ylsulfanyl)-ethyl]-1,3-oxazolidin-2-one (OXB1) is a new Benzimidazole derivative which was synthesized in our laboratory then characterized with several physicochemical techniques. However, its related toxic effect remains unknown. The present work aims to study its acute toxicity in normal Wistar rats. Six groups of rats received an intrapéritonéale (i.p.) injection of different doses of OXB1 (500, 700, 900, 1000 and 1200mg/kg) and were daily monitored for 14 days. Mortalities, changes in food and water uptake, behavioral changes and weight were monitored. The OXB1 Lethal Dose 50 (LD50) was 1084mg/kg. The administration of the studied molecule at a dose of 900mg/kg did not affect animal viability and body weight (bw). In addition, food and water intake are unchanged. Furthermore, at the this dose, the levels of hematological and biochemical values and organ’s weights were not affected which confirm that the No-Observed-Adverse-Effect Level (NOAEL) dose of OXB1 is 900 mg/kg in normal Wistar rats and could possibly be tested after further analysis in a preliminary clinical test.
Cite this article:
Abdellatif Bouayyadi, Ahmed Moussaif, Lahcen Bouayyadi, Aboubaker El Hessni, El Mokhtar Essassi, Mohammed El Mzibri, Abdelhalem Mesfioui. Acute Toxicity Evaluation of a new Benzimidazole derivative on the wistar rat. Research Journal of Pharmacy and Technology. 2022; 15(6):2427-2. doi: 10.52711/0974-360X.2022.00404
Cite(Electronic):
Abdellatif Bouayyadi, Ahmed Moussaif, Lahcen Bouayyadi, Aboubaker El Hessni, El Mokhtar Essassi, Mohammed El Mzibri, Abdelhalem Mesfioui. Acute Toxicity Evaluation of a new Benzimidazole derivative on the wistar rat. Research Journal of Pharmacy and Technology. 2022; 15(6):2427-2. doi: 10.52711/0974-360X.2022.00404 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-6-8
REFERENCES:
1. Nandini R Pai, Deepnandan S Dubhashi. Pharmacological Evaluation of Substituted Benzeneacetic Acid Ester Derivatives for Their Sedative, Antibacterial and Antifungal Potential. Research J. Pharm. and Tech. 3(2): April- June 2010; Page 570-577.
2. Michele Tonelli, Giuseppe Paglietti, Vito Boido, Fabio Sparatore, Fabio Marongiu, Esther Marongiu, Paolo La Colla, Roberta Loddo. Antiviral activity of benzimidazole derivatives. I. Antiviral activity of 1- substituted-2-[(benzotriazol-1/2- yl)methyl]benzimidazoles. Chem Biodivers 2008; 5(11): 2386-401.doi.org/10.1002/cbdv.200890203
3. Kale Sachin. C, Upadhayay Ashutosh, Kale M. K. Synthesis, Medicinal Applications and QSAR Study of Benzimidazole, Thiophene, Piperazine derivatives for Antimycobacterial, Antibacterial, Antifungal Activities. Research J. Pharm. and Tech 2018; 11(12): 5385-5393. doi: 10.5958/0974-360X.2018.00983.6
4. Chaitanya Prasad Meher, Abinash Kumar Sahu, Srimanta Kumar Dash, Ranjan Kumar Sahoo, Subodha Chandra Sahu, Dillip Kumar Gupta. Designing and Synthesis of some Novel 2-Substituted Benzimidazole Derivatives and their Evaluation for Antimicrobial and Anthelmintic Activity. Asian J. Research Chem. 2019; 12(2):58-62. doi: 10.5958/0974-4150.2019.00013.0
5. Sudheer K Dokuparthi, J. Baloji Naik K. Sunil Kumar, A. Saidulu. Synthesis, Characterization and Biological Evaluation of Benzimidazole Derivatives as Potential Anxiolytics. Research J. Pharm. and Tech. 2018; 11(1): 221-226. doi: 10.5958/0974-360X.2018.00041.0
6. Kanimozhi. P, Karthikeyan.J. Modulation of Antioxidant Potential in Liver of Albino rats by seeds of Nelumbo nucifera Gaertn. in 1,4 Dichlorobenzene induced hepatotoxicity. Research J. Pharm. and Tech. 5(4): April 2012; Page 538-540.
7. Deepak Kardile, Mrunal Shirsat. In vitro Antimicrobial and Antitubercular screening of newly synthesized Mercaptobenzimidazole –clubbed chalcone derivatives. Research J. Pharm. and Tech. 2021; 14(1):450-454. doi: 10.5958/0974-360X.2021.00082.2
8. Sanjeev Sharma, P.D. Gokulan, P.S. Jadon, Sanjay Singh, S.S. Shukla. Synthesis and Biological Evaluation of Some New Benzimidazole Derivatives For their Anticonvulsant and Anti-inflammatory activity. Research J. Pharm. and Tech. 4(8): August 2011; Page 1311-1319.
9. D. S. Bele, I. Singhvi. Synthesis and Analgesic Activity of Some Mannich Bases of 6-Substituted-2-Aminobenzothiazole. Research J. Pharm. and Tech. 1(1): Jan.-Mar. 2008; Page 22-24.
10. Viral Patel. Design, Development, Evaluation and Optimization of Antiulcer Delayed Release Tablets. Research J. Pharm. and Tech 6(6): June 2013; Page 669-684.
11. Ravi N Tiwari, KG Bothara, Gurmeet Singh Chhabra, Sarang Kulkarni. Evaluation of Anticonvulsant Activity of Novel Substituted 2-Mercaptobenzimidazole Derivatives. Research J. Pharm. and Tech. 3(2): April- June 2010; Page 466-467.
12. Deepak Kardile, Mrunal Shirsat. Synthesis and Evaluation of Antimicrobial, Antitubercular and Anticancer activities of Dihydro Benzimidazole thiopyran oxazinone derivatives. Research J. Pharm. and Tech 2021; 14(3):1453-1458. doi: 10.5958/0974-360X.2021.00259.6
13. Bouayyadi A, el al. Molecular docking analysis of α2-containing GABAA receptors with benzimidazoles derivatives. Bioinformation. 2020 Aug 31;16(8):611-619. doi: 10.6026/97320630016611. PMID: 33214749; PMCID: PMC7649024.
14. El harti Jaouad, Adouani Badr, Benmoussa Adnane, Ansar M’ hammed, Taoufik Jamal. Benzimidazoles and Pharmacological Activities: A Review. Research J. Pharm. and Tech. 7(4): April, 2014; Page 481-488.
15. Yogendra Nayak, Jayashree B.S., Unnikrishnan M.K. Benzopyran-4-one is an Ideal Pharmacophore for Lead Optimization in Antidiabetic Drug Discovery. Research J. Pharm. and Tech. 5(8): August 2012; Page 1025-1033.
16. Gurvinder, S et al. "International research journal of pharmacy." Int. Res. J. Pharm. 4 (2013): 82-87. ISSN 2230 – 8407
17. Moussaif A, et al. 3-[2-(1H-Benzimidazol-2- ylsulfanyl) ethyl]-1, 3-oxazolidin-2-one. Acta Crystallogr Sect. E Struct Rep Online. 2010 Dec 1; 66(Pt 12): o3137.
18. Bouayyadi A et al. Synthesis and characterization of novel Benzimidazole derivatives. World Journal of Pharmaceutical Research 2016 5(7):61
19. Viala A and Botta A. (2005). Toxicologie, 2 ème édition. Paris: Tec α Doc Lavoisier, 25-46.
20. Organisation for Economic Cooperation and Development (OECD), Harmonized Integrated Hazard Classification System for Human Health and Environmental Effects of Chemical Substances, Part 2, Paris (2001), pp. 20–24.
21. Descat Fleur., Hématologie du rat: Hémogramme et myogramme, Thèse, Université de Toulouse, 2002. P.91-93.
22. Lazare, T et al. (2011). Alcoolisation chronique des rats (Rattusnorvegicus) de souche Wistar à une eau-de-vie traditionnelle produit en Côte d’Ivoire (Koutoukou). Journal of Applied Biosciences 41 (2011): 2772-2779.
23. Archives Internationales de Pharmacodynamie et de Thérapie, vol. 95, p. 123, 1953.
24. Xiong H. and Pamer E.G. Monocytes and infection: Modulator, messenger and effector, Immunobiology, 2015, 220(2), 210–214.
25. Willhite, C.C and Katz, P.I. (1984) Toxicology Updates: Dimethyl Sulfoxide. Journal of Applied Toxicology 4 (3): 155-160
26. Sirwal I.A, et al. (2004). Estimation of glomerular filteration rate (GFR). JK Science 6.3 (2004): 121-3.